180 Life Sciences Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on October 31, 2024. The registrant is incorporated in Delaware and maintains its principal executive offices in Palo Alto, California. The report discloses a material corporate event under Regulation FD.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the engagement of a Senior Technology Consultant, as detailed in the press release attached as Exhibit 99.1. No financial or operational changes relative to a prior comparable period are reported in this document.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the standard disclaimer that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act. The engagement of the consultant is the sole substantive update provided.
Investor Verification Checklist
- Verify the specific role and scope of the newly engaged Senior Technology Consultant via the attached press release (Exhibit 99.1).
- Confirm the company's ticker symbols: Common Stock (ATNF) and Warrants (ATNFW) on The NASDAQ Stock Market LLC.
- Note that the report is signed by Blair Jordan, the Interim Chief Executive Officer.
- Review subsequent filings for any financial impact resulting from this engagement, as none is quantified here.